✦ LIBER ✦
9129 POSTER Safety Profile and Efficacy of Erlotinib in a Japanese Post-marketing Surveillance Study of 10,708 Non-small-cell Lung Cancer (NSCLC) Patients (pts) – Interim Analyses From the First 3,488 Pts
✍ Scribed by Ohe, Y.; Fukuoka, M.; Kudoh, S.; Nakagawa, K.; Johkoh, T.; Ando, M.; Yamazaki, N.; Takemoto, S.; Seki, A.
- Book ID
- 122904190
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 44 KB
- Volume
- 47
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.